Noncontiguous Stage II Mantle Cell Lymphoma Active Not Recruiting Phase 1 / 2 Trials for Mycophenolate mofetil (DB00688)

IndicationStatusPhase
DBCOND0028643 (Noncontiguous Stage II Mantle Cell Lymphoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00078858Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantTreatment